Oxford's Corona vaccine government succeeds in developing antibodies not only for the young but also for the elderly

London, Ta. Monday, October 26, 2020

The spread of the corona virus is increasing worldwide. Then all the people of the world are waiting for a successful vaccine to come and get rid of this disease. Especially the elderly are at the highest risk of coronavirus. The question then is whether the corona vaccine that will come will be effective for the elderly. This is because the immune system of the elderly is very low. The corona vaccine, developed by Oxford and AstraZeneca in Teva, has been shown to be effective in the elderly.

Many corona vaccines are being developed around the world. Oxford's corona vaccine is the most promising of all. The third phase of the covishield vaccine is currently being tested. The trial found that the vaccine was effective not only for the young but also for the elderly. The vaccine has also developed antibodies in the elderly, which are able to fight corona.

The corona vaccine has caused the development of antibodies and T cells in the elderly, according to a report. Antibodies and T cells play an important role in fighting any disease. Most vaccines only develop antibodies, while these vaccines also produce T cells.